₹ 140.89 Cr
1.04%
NIFTY 100 Equal Weight TRI
INF754K01LR3
100.0
100.0
500
Bhavesh Jain, Amit Vora
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
Edelweiss MSCI India Domestic & World Healthcare 45 index Fund Regular Plan - Growth | 38.51 | 12.32 | - |
NIFTY 100 Equal Weight TRI | 47.26 | 20.96 | 20.28 |
Equity
Debt
Others
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.78 |
Cipla Ltd. | 7.02 |
Dr. Reddy's Laboratories Ltd. | 6.92 |
Max Healthcare Institute Ltd. | 6.24 |
Apollo Hospitals Enterprise Ltd. | 5.72 |
Eli Lilly And Co | 5.01 |
Divi's Laboratories Ltd. | 4.57 |
Lupin Ltd. | 3.58 |
Novo Nordisk A/S - ADR | 3.14 |
Aurobindo Pharma Ltd. | 2.91 |
Sector | Holdings (%) |
---|---|
Healthcare | 99.97 |
Others | 0.03 |